Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Rare tumour removed in groundbreaking surgery
2011-08-06

 

Mr Carel Botes and Prof. Francis Smit with a model of the human heart
Photo: Earl Coetzee

A team of surgeons, headed by Prof Francis Smit, Head of our Department of Cardiothoracic Surgery at our Faculty of Health Sciences, performed open heart surgery on a male patient with a malignant tumour.

What makes this operation unique, is that the suspicious mass that was identified in the heart was a rapidly growing and a highly invasive cardiac tumour, which has only been seen in a small number of patients worldwide.

Without the necessary surgery or heart transplant, the prognosis of the patient would have been zero.

The patient, Mr Carl Botes, a 51-year-old farmer from Hoopstad, opted for the tumour to be removed rather than having a heart transplant.  Although both options would involve major risks and challenges, the transplant was the least feasible due to logistics, the waiting list for recipients and the lack of donors.

In the, highly complex, 10-hour operation, performed in the Universitas Academic Hospital in Bloemfontein, the entire right heart chamber had to be removed and the heart reconstructed.

After prolonged hospitalisation of five weeks, Mr Botes was discharged.

Currently he is fully functional and continuing with his active lifestyle.  After three months, all investigations and scans indicate that he is doing very well and has no complaints of fatigue, shortness of breath and palpitations – symptoms which occurred before the removal of the tumour.

For further information contact:
Prof Francis Smit
051-4053861
smitfe@ufs.ac.za
 

Media Release
6 August 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept